vs
Side-by-side financial comparison of IT TECH PACKAGING, INC. (ITP) and SCYNEXIS INC (SCYX). Click either name above to swap in a different company.
IT TECH PACKAGING, INC. is the larger business by last-quarter revenue ($25.6M vs $18.6M, roughly 1.4× SCYNEXIS INC). SCYNEXIS INC runs the higher net margin — 65.7% vs -5.7%, a 71.4% gap on every dollar of revenue. On growth, SCYNEXIS INC posted the faster year-over-year revenue change (1808.5% vs 2.1%). Over the past eight quarters, SCYNEXIS INC's revenue compounded faster (268.5% CAGR vs 10.5%).
IT TECH PACKAGING, INC. is a paper manufacturing enterprise primarily operating in China. It produces and distributes a diverse portfolio of paper products including corrugated packaging paper, boxboard, and printing-use cultural paper, serving sectors such as consumer goods packaging, logistics, and commercial printing across its core market.
SCYNEXIS Inc. is a biotechnology company focused on developing innovative antifungal therapies to address unmet medical needs for difficult-to-treat fungal infections. It targets hospital and specialty care markets, with key product candidates serving immunocompromised patients and other high-risk groups.
ITP vs SCYX — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $25.6M | $18.6M |
| Net Profit | $-1.4M | $12.3M |
| Gross Margin | 7.9% | — |
| Operating Margin | -3.9% | 56.3% |
| Net Margin | -5.7% | 65.7% |
| Revenue YoY | 2.1% | 1808.5% |
| Net Profit YoY | 26.6% | 376.5% |
| EPS (diluted) | $-0.11 | $0.25 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $18.6M | ||
| Q3 25 | $25.6M | $334.0K | ||
| Q2 25 | $24.8M | $1.4M | ||
| Q1 25 | $10.9M | $257.0K | ||
| Q4 24 | $17.6M | $977.0K | ||
| Q3 24 | $25.1M | $660.0K | ||
| Q2 24 | $26.2M | $736.0K | ||
| Q1 24 | $6.9M | $1.4M |
| Q4 25 | — | $12.3M | ||
| Q3 25 | $-1.4M | $-8.6M | ||
| Q2 25 | $-2.0M | $-6.9M | ||
| Q1 25 | $-3.5M | $-5.4M | ||
| Q4 24 | $-4.0M | — | ||
| Q3 24 | $-2.0M | $-2.8M | ||
| Q2 24 | $-77.7K | $-14.5M | ||
| Q1 24 | $-3.7M | $411.0K |
| Q4 25 | — | — | ||
| Q3 25 | 7.9% | — | ||
| Q2 25 | 5.1% | — | ||
| Q1 25 | 0.8% | — | ||
| Q4 24 | 6.3% | — | ||
| Q3 24 | 7.6% | — | ||
| Q2 24 | 12.4% | — | ||
| Q1 24 | 5.8% | — |
| Q4 25 | — | 56.3% | ||
| Q3 25 | -3.9% | -2516.5% | ||
| Q2 25 | -7.1% | -701.0% | ||
| Q1 25 | -31.0% | -3350.2% | ||
| Q4 24 | -21.5% | — | ||
| Q3 24 | -5.8% | -1563.6% | ||
| Q2 24 | 2.1% | -1255.0% | ||
| Q1 24 | -51.0% | -692.5% |
| Q4 25 | — | 65.7% | ||
| Q3 25 | -5.7% | -2572.2% | ||
| Q2 25 | -7.9% | -504.8% | ||
| Q1 25 | -32.2% | -2097.7% | ||
| Q4 24 | -22.9% | — | ||
| Q3 24 | -7.9% | -425.5% | ||
| Q2 24 | -0.3% | -1964.4% | ||
| Q1 24 | -54.6% | 29.9% |
| Q4 25 | — | $0.25 | ||
| Q3 25 | $-0.11 | $-0.17 | ||
| Q2 25 | $-0.16 | $-0.14 | ||
| Q1 25 | $-0.35 | $-0.11 | ||
| Q4 24 | $-0.40 | — | ||
| Q3 24 | $-0.20 | $-0.06 | ||
| Q2 24 | $-0.01 | $-0.30 | ||
| Q1 24 | $-0.37 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $40.0M |
| Total DebtLower is stronger | $4.7M | — |
| Stockholders' EquityBook value | $152.0M | $49.4M |
| Total Assets | $175.7M | $59.0M |
| Debt / EquityLower = less leverage | 0.03× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $40.0M | ||
| Q3 25 | — | $37.9M | ||
| Q2 25 | — | $44.8M | ||
| Q1 25 | — | $40.6M | ||
| Q4 24 | — | $59.3M | ||
| Q3 24 | — | $68.8M | ||
| Q2 24 | — | $73.0M | ||
| Q1 24 | — | $80.2M |
| Q4 25 | — | — | ||
| Q3 25 | $4.7M | — | ||
| Q2 25 | $4.7M | — | ||
| Q1 25 | $4.7M | — | ||
| Q4 24 | $4.7M | — | ||
| Q3 24 | $8.9M | — | ||
| Q2 24 | $11.3M | — | ||
| Q1 24 | $11.4M | — |
| Q4 25 | — | $49.4M | ||
| Q3 25 | $152.0M | $36.4M | ||
| Q2 25 | $152.3M | $44.5M | ||
| Q1 25 | $152.8M | $50.5M | ||
| Q4 24 | $156.1M | $55.1M | ||
| Q3 24 | $164.3M | $58.5M | ||
| Q2 24 | $163.5M | $60.4M | ||
| Q1 24 | $164.3M | $74.1M |
| Q4 25 | — | $59.0M | ||
| Q3 25 | $175.7M | $51.1M | ||
| Q2 25 | $175.2M | $60.7M | ||
| Q1 25 | $175.2M | $67.9M | ||
| Q4 24 | $177.5M | $90.6M | ||
| Q3 24 | $190.0M | $99.0M | ||
| Q2 24 | $191.4M | $107.8M | ||
| Q1 24 | $177.5M | $118.3M |
| Q4 25 | — | — | ||
| Q3 25 | 0.03× | — | ||
| Q2 25 | 0.03× | — | ||
| Q1 25 | 0.03× | — | ||
| Q4 24 | 0.03× | — | ||
| Q3 24 | 0.05× | — | ||
| Q2 24 | 0.07× | — | ||
| Q1 24 | 0.07× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.5M | $18.4M |
| Free Cash FlowOCF − Capex | $1.5M | — |
| FCF MarginFCF / Revenue | 5.9% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | 1.50× |
| TTM Free Cash FlowTrailing 4 quarters | $3.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $18.4M | ||
| Q3 25 | $1.5M | $-8.7M | ||
| Q2 25 | $1.4M | $-7.5M | ||
| Q1 25 | $-2.5M | $-7.5M | ||
| Q4 24 | $3.5M | $-24.0M | ||
| Q3 24 | $1.5M | $765.0K | ||
| Q2 24 | $721.9K | $-10.9M | ||
| Q1 24 | $624.4K | $-4.0M |
| Q4 25 | — | — | ||
| Q3 25 | $1.5M | — | ||
| Q2 25 | $1.3M | — | ||
| Q1 25 | $-2.5M | — | ||
| Q4 24 | $3.5M | — | ||
| Q3 24 | $1.2M | — | ||
| Q2 24 | $668.3K | — | ||
| Q1 24 | $615.4K | — |
| Q4 25 | — | — | ||
| Q3 25 | 5.9% | — | ||
| Q2 25 | 5.4% | — | ||
| Q1 25 | -22.8% | — | ||
| Q4 24 | 19.6% | — | ||
| Q3 24 | 4.9% | — | ||
| Q2 24 | 2.5% | — | ||
| Q1 24 | 9.0% | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 1.0% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | — | 1.50× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -9.75× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ITP
Segment breakdown not available.
SCYX
| Glaxosmithkline Intellectual Property | $17.2M | 92% |
| Products | $1.4M | 8% |
